Agenda and supporting papers - Plymouth Hospitals NHS Trust
Agenda and supporting papers - Plymouth Hospitals NHS Trust
Agenda and supporting papers - Plymouth Hospitals NHS Trust
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
OTHER<br />
ACCESS & ACTIVITY<br />
Acting Chief Operating Officer<br />
WORKFORCE<br />
Human Resources Director<br />
SAFETY & QUALITY<br />
Medical Director & Acting Chief Nurse<br />
FINANCE & EFFICIENCY<br />
Acting Director of Finance<br />
A1<br />
Summary performance dashboard - May 2013<br />
Status Ranking Page Metric Status Page<br />
Safe Care<br />
Income & Expenditure<br />
Hospital St<strong>and</strong>ardised Mortality Ratio (HSMR Relative Risk) 83.0 YTD 1/17 (SW YTD) £000s variance from plan (Month) (26)<br />
Summary Hospital-Level Mortality Indicator (SHMI ) 95.5 YTD 6/17 (SW YTD) £000s variance from plan (Year To Date) (54)<br />
D1<br />
% Surgical safety checklist completion 98.0% M2<br />
B1<br />
Cost Improvement Programme<br />
Incidents Reporting Rate (per 100 admissions) 9.70 M2 Full year forecast variance from target (£000s) 1,700<br />
% incidents leading to harm, loss or damage 32% M2 CIPs Delivered (£000s) 6,048<br />
Effective Care<br />
CIPs Forecast as Green Risk (£000s) 10,937 D2<br />
Readmissions (13 Month Avg Relative Risk) 97.0 YTD 12/17 (SW YTD) B2 CIPs Forecast as Amber Risk (£000s) 7,274<br />
Patient Experience<br />
CIPs Forecast as Red Risk (£000s) 1,441<br />
Friends <strong>and</strong> Family Test Response Rate (Inpatient) 13.7% M2<br />
Capital Expenditure<br />
Friends <strong>and</strong> Family Test Response Rate (ED) 8.4% M2 % of capital programme spent 12% D3<br />
Complaints closed within target (%) 85% M2<br />
B3<br />
Cash Management<br />
Non-clinically justified mixed sex breaches (No.) 0 M2 Revised Planned Closing Cash Balance (£'000s) 3,226<br />
Cancelled operations (% of elective FFCEs) 1.96% YTD Actual Closing Cash Balance (£'000s) 8,761<br />
Infection Control<br />
Cleared Balances (£'000s) 9,409<br />
MRSA cases (hospital apportioned) 0 YTD 8 / 17 (SW YTD) BPPC - <strong>NHS</strong> Volume (% within target) 97% D4<br />
B4<br />
C-Diff cases (hospital apportioned) 4 YTD 4 / 17 (SW YTD) BPPC - <strong>NHS</strong> Value (% within target) 98%<br />
Other key safety & quality metrics<br />
BPPC - Non-<strong>NHS</strong> Volume (% within target) 95%<br />
% stroke patients >90% of time on stroke unit 62.6% YTD BPPC - Non-<strong>NHS</strong> Value (% within target) 90%<br />
B5<br />
Follow-up backlog - actual (no.of patients) 24305 YTD<br />
Contract Penalties<br />
Accident & Emergency<br />
Contract Penalties - Year-to-Date (£000's) 427 D5<br />
% of A&E patients waiting 30 mins) 1.7% YTD C1<br />
Discretionary Spend (£000s) 1380<br />
Delayed transfers of care (delayed days as % of occupied days) 1.7% YTD Vacancy % - Nursing 5.52%<br />
Cancer Services<br />
Vacancy % - Medical 7.07% E1<br />
31 days from 'decision to treat' (%) 98.7% YTD 102/168 (Nat Q3) Vacancy % - Admin & Managers 6.60%<br />
62 days from urgent GP referral (%) 83.1% YTD 153/167 (Nat Q3) Vacancy % - Other Staff 6.47%<br />
62 days from screening referral to treat (%) 85.4% YTD 133/145 (Nat Q3)<br />
Training & Appraisals<br />
62 days from consultant upgrade to treat (%) 95.7% YTD 64/154 (Nat Q3) Basic Life Support (% completed) 87%<br />
31 days - DTT to subsequent - surgery (%) 95.6% YTD 140/162 (Nat Q3) C3<br />
Manual H<strong>and</strong>ling (% completed) 92%<br />
31 days - DTT to subsequent - drugs (%) 99.2% YTD 4/152 (Nat Q3) Essential Skills (% completed) 95% E2<br />
31 days - DTT to subsequent - rad'th'py (%) 97.8% YTD 69/78 (Nat Q3) Child Protection (% completed) 97%<br />
2 weeks for breast symptom referral (%) 95.9% YTD 43/143 (Nat Q3) Appraisals (% completed) 82%<br />
2 weeks from urgent GP referral (%) 94.1% YTD 150/170 (Nat Q3)<br />
Referral To Treatment (RTT)<br />
18 weeks - Admitted patients (%) 88.3% M2 160/174 (Nat M12)<br />
18 weeks - Non-admitted patients (%) 95.9% M2 195/207 (Nat M12)<br />
18 weeks - Audiology Direct Access (%) 97.3% M2<br />
C4<br />
% Incomplete pathways within 18 weeks 90.3% M2 187/206 (Nat M12)<br />
Other key access & activity metrics<br />
% patients waiting >6 weeks for diagnostic test 2.8% M2 C6<br />
Sickness Absence<br />
<strong>Trust</strong> Sickness Absence Rate (Average %) 3.63% E3<br />
External Assessments<br />
Monitor's Governance Risk Rating<br />
Monitor's Financial Risk Rating<br />
Red 0% (4.0)<br />
2<br />
F1<br />
F2<br />
3